Home | About us | Editorial board | Search | Ahead of print | Current issue | Archives | Submit article | Instructions | Subscribe | Contacts | Advertise | Login 
 
Search Article 
  
Advanced search 
  Users Online: 275 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
MINI REVIEW
Year : 2012  |  Volume : 16  |  Issue : 8  |  Page : 233-235

Low density Lipoprotein cholesterol target: Changing goal posts


Department of Endocrinology, St. Johns Medical College Hospital, Bangalore - 560 034, Karnataka, India

Correspondence Address:
Ganapathi Bantwal
Department of Endocrinology, St. Johns Medical College Hospital, Bangalore - 560 034
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/2230-8210.104047

Rights and Permissions

Elevated low density lipoprotein cholesterol (LDL) has been identified as one of the strongest correctable risk factors for cardiovascular disease in patients with diabetes. The reduction in cardiovascular events with pharmacological therapy aimed at LDL lowering is well documented in both primary prevention and secondary prevention. In this article, we review the evolving trend of aggressive LDL cholesterol lowering strategies.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed1072    
    Printed24    
    Emailed0    
    PDF Downloaded235    
    Comments [Add]    

Recommend this journal